Skip to main content
Premium Trial:

Request an Annual Quote

Rising R&D, SG&A Costs Lead to Wider Q1 Net Loss for Rosetta Genomics

NEW YORK (GenomeWeb News) - Rosetta Genomics today said it generated no first-quarter sales, while its R&D spending climbed 30 percent, and its net loss increased 33 percent year over year.
 
Rosetta, which went public in February, said that R&D spending for the three months ended March 31, 2007, increased to $1.16 million from $886,000 in the year-ago period. R&D accounted for 52 percent of the company’s spending during the quarter.
 
The increase in R&D spending resulted primarily from increased costs related to the purchase of tissue samples and other research materials related to its Cancer of Unknown Primary (CUP) diagnostic program, “as well as an increase in costs relating to our intellectual property and costs associated with license fees,” the company said in a statement.
 
General and administrative expenses increased to $680,000 from $211,000 in the first quarter of 2006. Rosetta Genomics said these higher costs were due to legal and other fees associated with its initial public offering and operation as a public company.
 
The company’s quarterly net loss increased to $2 million from $1.5 million in the first quarter of 2006.
 
Rosetta Genomics said it had around $10.8 million in cash and cash equivalents as of March 31.
The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.